Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency (Q35676196)
scientific article published on February 2004
Language:
Current Data About Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency
(P31) (Q13442814)
(P248)
(P698) 14985489
(P813) Wednesday, August 9, 2017

(P50) (Q15989727)
(P1932) Terence H Rabbitts
(P1545) 2

(P304) 913-922
(P248)
(P698) 14985489
(P813) Wednesday, August 9, 2017

(P407) (Q1860)

(P433) 9
(P248)
(P698) 14985489
(P813) Wednesday, August 9, 2017

(P478) 350
(P248)
(P698) 14985489
(P813) Wednesday, August 9, 2017

(P577) Sunday, February 1, 2004
(P248)
(P698) 14985489
(P813) Wednesday, August 9, 2017

(P921) (Q213901)

(Q1334408)
(P887)

(P1433) (Q582728)
(P248)
(P698) 14985489
(P813) Wednesday, August 9, 2017

(P1476) "Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency" (language: en)
(P248)
(P698) 14985489
(P813) Wednesday, August 9, 2017

(P2093) Matthew P McCormack
(P1545) 1
(P248)
(P698) 14985489
(P813) Wednesday, August 9, 2017

(P13046) (Q7318358)
(P248)

other details
description scientific article published on February 2004

External Links
(P356) 10.1056/NEJMRA032207
(P698) 14985489